A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"

  1. López-Jaramillo, P.
  2. Pradilla, L.P.
  3. Lahera, V.
  4. Silva Sieger, F.A.
  5. Rueda-Clausen, C.F.
  6. Márquez, G.A.
Zeitschrift:
Trials

ISSN: 1745-6215 1745-6215

Datum der Publikation: 2006

Ausgabe: 7

Art: Artikel

DOI: 10.1186/1745-6215-7-28 GOOGLE SCHOLAR lock_openOpen Access editor